Patient care
For 50 years, DMEI’s national reputation has drawn some of the brightest minds in vision care to Oklahoma who have given the gift of sight to tens of thousands using the latest clinical and surgical techniques, cutting-edge technology, and compassionate care. Our dedicated team of eye care specialists delivers advanced treatments tailored to each patient’s unique needs, ensuring the best possible medical outcomes. Your support today fuels the next chapter of our mission and helps us continue to provide high quality, compassionate eye care to all those we serve regardless of ability to pay.
Vision Research
At DMEI, vision research is the lens through which we see a brighter future. Over the past 50 years, our vision scientists have been on the leading edge of research to understand the causes of eye disease and use that knowledge to undertake novel approaches to treatment. As we honor this legacy, we remain focused on accelerating new breakthroughs in such areas as retinal degenerations, glaucoma, and infectious and inflammatory diseases of the eye using small molecules, antioxidants, stem cells, metabolic reprogramming, lipid nanotechnology, and other approaches. Your generosity powers this cutting-edge research that will shape the future of vision for generations to come.
Education
Visionaries aren’t born—they’re trained. For five decades, DMEI has been a national leader in ophthalmology education, cultivating the next generation of ophthalmologists through our renowned residency program in conjunction with the University of Oklahoma College of Medicine’s Department of Ophthalmology and DMEI’s fellowship programs. As we celebrate this anniversary, we remain committed to educating tomorrow’s leaders in eye care. Your contributions provide advanced training and invaluable learning opportunities—ensuring that the future of vision care is in capable hands.
DMEI resident Ashley Ooms, MD, explores gray area strabismus surgery complications in AUPO poster
February 10th 2025Ooms' poster at the Association of University Professors of Ophthalmology annual meeting highlighted a study on gray area complications in strabismus surgery, showing that trainees are more likely than attendings to disclose these complications despite having similar baseline anxiety levels. Ooms is a PGY-4 ophthalmology resident at the Dean McGee Eye Institute.
Dean McGee Eye Institute secures $800,000 in research and academic grants
January 25th 2025Funds from the Inasmuch Foundation and The Samuel Roberts Noble Foundation will support the purchase of equipment, including computerized eye simulators, a laser injector, and a device for measuring the electrical resistance of cells.
AAO 2024: New study shows promise for MICE procedure in treating corneal neovascularization
October 22nd 2024Kamran Riaz, MD, discussed with the Eye Care Network a study on mitomycin intravascular chemoembolization for treating corneal neovascularization. The procedure showed promise, with a 70% success rate at 3 to 6 months, though patient selection is crucial. Some required multiple treatments, but overall outcomes are promising.
Jane C. Edmond, MD, starts term as 2024 president of AAO
January 13th 2024According to an American Academy of Ophthalmology news release, Edmond’s priorities during her term include addressing physician and staff shortages and protecting patient safety at a time when nonphysicians are trying to expand their scope of practice into eye surgery.
Trends in corneal treatment include cutting-edge advancements
March 15th 2023Kamran M. Riaz, MD, a clinical associate professor and director of Medical Student Research at the Dean A. McGee Institute at the University of Oklahoma, recently discussed with Ophthalmology Times some of the latest trends in cornea treatment.
Research to Prevent Blindness awards grant to OU Department of Ophthalmology
July 12th 2022The University of Oklahoma Health Sciences Center has received an unrestricted grant from Research to Prevent Blindness for $575,000 over 5 years to support eye research conducted by the Department of Ophthalmology.
Surgery developed by ophthalmologist at Dean McGee Eye Institute proves its effectiveness
December 21st 2021Mahmoud A. Khaimi, MD, developed a minimally invasive glaucoma surgery known as ab-interno canaloplasty as a treatment option between topical therapies and invasive surgery. The technique continues to prove its value.